Report Scope:
The current report provides details about drug molecules that have been or will be launched in the market in 2019. This report highlights information and insights on the molecules. The report includes drug overviews, mechanisms of action, disease backgrounds, currently available treatments for diseases that these drugs address, clinical evidence on safety and efficacy, regulatory scenarios, market scope of the drugs and company profiles of manufactures.

Report Includes:

  • Information on the top potential drug launches by pharma companies in 2019
  • Knowledge about drug, mechanism of action, and briefing of clinical evidences
  • Detailed information and insights on the drug Upadacitinib which is manufactured by AbbVie Inc. , Ultomiris (ravulizumab-cwvz) a humanized monoclonal antibody manufactured by Alexion Pharmaceuticals Inc. and many more
  • Insights into regulatory approvals, market scope, and analysis of pipeline molecules
  • Detailed profiles of the companies and competitors related to the industry